{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:41:17Z","timestamp":1759412477829},"reference-count":47,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2002,9,9]],"date-time":"2002-09-09T00:00:00Z","timestamp":1031529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Medical Virology"],"published-print":{"date-parts":[[2002,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Type 1, 2, and 3 vaccine\u2010derived polioviruses were isolated from a sewage disposal plant located downstream of the Oyabe River in Toyama Prefecture, Japan, between October 1993 and September 1995. Neurovirulence was analyzed in 13 type 1 vaccine\u2010derived strains, using mutant analysis by polymerase chain reaction and restriction enzyme cleavage (MAPREC). Nine strains (69%) were estimated to have marked neurovirulence. Some of the neutralizing antigenic sites, temperature sensitivity, and plaque\u2010forming ability of two virulent vaccine\u2010derived poliovirus strains were similar to Mahoney strain. The neutralizing activity of human sera obtained after oral poliomyelitis vaccine (OPV) administration against one of the virulent vaccine\u2010derived polioviruses was examined. Although all human sera showed sufficient neutralizing activity for the prevention of poliomyelitis by vaccine\u2010derived poliovirus strains, a lower titer than that against Sabin type 1 strain was observed. Vaccination against virulent vaccine\u2010derived poliovirus will be effective. However, the environmental presence of viruses that have properties similar to those Mahoney strain is a threat. The introduction of inactivated poliovirus vaccine (IPV), and well\u2010maintained herd immunity, together with reinforced environmental surveillance is important for the final phase of the polio eradication program by the World Health Organization (WHO). J. Med. Virol. 68:445\u2013451, 2002. \u00a9 2002 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/jmv.10224","type":"journal-article","created":{"date-parts":[[2002,10,8]],"date-time":"2002-10-08T22:56:53Z","timestamp":1034117813000},"page":"445-451","source":"Crossref","is-referenced-by-count":21,"title":["Isolation of vaccine\u2010derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan"],"prefix":"10.1002","volume":"68","author":[{"given":"Hitoshi","family":"Horie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromu","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumiko","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwako","family":"Miyazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Nomoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"So","family":"Hashizume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,9,9]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a120717"},{"key":"e_1_2_1_3_1","first-page":"1094","article-title":"Outbreak of poliomyelitis\u2014Dominican Republic and Haiti, 2000","volume":"49","author":"Centers for Disease Control and Prevention","year":"2000","journal-title":"MMWR"},{"key":"e_1_2_1_4_1","first-page":"41","article-title":"Circulation of a type 2 vaccine\u2010derived poliovirus\u2014Egypt, 1982\u20131993","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR"},{"key":"e_1_2_1_5_1","first-page":"874","article-title":"Public health dispatch: Acute flaccid paralysis associated with circulating vaccine\u2010derived poliovirus\u2014Philippines, 2001","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.64.10.4922-4929.1990"},{"key":"e_1_2_1_7_1","first-page":"67","article-title":"Molecular consistency monitoring of oral poliovirus vaccine and other live viral vaccines","volume":"100","author":"Chumakov KM","year":"1999","journal-title":"Dev Biol"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.1.199"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890420115"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1045-1056(05)80003-X"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890320205"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/314548a0"},{"key":"e_1_2_1_13_1","doi-asserted-by":"crossref","first-page":"7758","DOI":"10.1128\/jvi.71.10.7758-7768.1997","article-title":"Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine\u2010associated paralytic poliomyelitis","volume":"71","author":"Georgescu MM","year":"1997","journal-title":"J Virol"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7041255"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.68.2.681-688.1994"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1006\/biol.1998.0159"},{"key":"e_1_2_1_17_1","doi-asserted-by":"crossref","unstructured":"HorieH Sato\u2010MiyazawaM OtaY WakabayashiK DoiT YoshizawaK DoiY HashizumeS.1999.Detection of mutants in polio vaccine viruses using pooled antipoliovirus monoclonal antibodies. Biologicals27:217\u2013226.","DOI":"10.1006\/biol.1999.0211"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00350-9"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.68.1.138-142.2002"},{"key":"e_1_2_1_20_1","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1128\/jvi.63.3.1302-1309.1989","article-title":"Determinants in the 5\u2032 non coding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype","volume":"63","author":"Kawamura N","year":"1989","journal-title":"J Virol"},{"key":"e_1_2_1_21_1","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1128\/jvi.53.3.786-792.1985","article-title":"In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain","volume":"54","author":"Kohara M","year":"1985","journal-title":"J Virol"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.3.951"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(91)90877-E"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.66.11.5087-5091.2000"},{"key":"e_1_2_1_25_1","first-page":"162","article-title":"Properties of poliovirus strains isolated over the period 1969\u20131978 from the main municipal sewerage system of the City of Prague","volume":"26","author":"Matyasova I","year":"1982","journal-title":"J Hyg Epidemiol Microbiol Immunol"},{"key":"e_1_2_1_26_1","first-page":"21","article-title":"Advantages and disadvantages of killed and live poliomyelitis vaccines","volume":"56","author":"Melnick JL","year":"1978","journal-title":"Bull World Health Organ"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/6.Supplement_2.S323"},{"issue":"4","key":"e_1_2_1_28_1","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1099\/0022-1317-80-4-907","article-title":"A Sabin vaccine\u2010derived field isolate of poliovirus type 1 displaying aberrant phenotypic and genetic features, including a deletion in antigenic site 1","volume":"80","author":"Mulders MN","year":"1999","journal-title":"J Gen Virol"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-1702(91)90002-D"},{"key":"e_1_2_1_30_1","first-page":"178","article-title":"Parameters for differentiating vaccine\u2010derived and wild poliovirus strains","volume":"24","author":"Nakano JH","year":"1978","journal-title":"Prog Med Virol"},{"key":"e_1_2_1_31_1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jama.1987.03390100073029","article-title":"Vaccine\u2010associated paralytic poliomyelitis, United States: 1973 through 1984","volume":"257","author":"Nkowane BM","year":"1987","journal-title":"JAMA"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4612-0407-7_6"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.63.11.4949-4951.1989"},{"key":"e_1_2_1_34_1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1128\/aem.54.2.371-374.1988","article-title":"Viruses in sewage waters during and after a poliomyelitis outbreak and subsequent nationwide oral poliovirus vaccination campaign in Finland","volume":"54","author":"Poyry T","year":"1988","journal-title":"Appl Environ Microbiol"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1994.02170050037007"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1994.1353"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/3.3.543"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-1157(73)90048-6"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(60)91791-8"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/168.6.1510"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.62.2.558-562.1988"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.63.3.1338-1344.1989"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1006\/biol.1997.0055"},{"key":"e_1_2_1_44_1","first-page":"30","article-title":"Requirements for poliomyelitis vaccine. WHO Expert Committee on Biological Standardization","volume":"800","author":"World Health Organization","year":"1990","journal-title":"Tech Rep Ser"},{"key":"e_1_2_1_45_1","volume-title":"Manual for the virological investigation of poliomyelitis","author":"World Health Organization","year":"1990"},{"key":"e_1_2_1_46_1","unstructured":"World Health Organization.1995.Manual of laboratory methods for potency testing of vaccines used in the WHO Expanded Programme on Immunization. WHO publication no. WHO\/BLG\/95.1. Geneva Switzerland: World Health Organization."},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02868-3"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-83-5-1107"}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjmv.10224","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jmv.10224","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T14:48:07Z","timestamp":1700318887000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.10224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9,9]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["10.1002\/jmv.10224"],"URL":"https:\/\/doi.org\/10.1002\/jmv.10224","archive":["Portico"],"relation":{},"ISSN":["0146-6615","1096-9071"],"issn-type":[{"value":"0146-6615","type":"print"},{"value":"1096-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,9,9]]}}}